Eleanor De Groot - Mar 30, 2022 Form 4 Insider Report for Alaunos Therapeutics, Inc. (TCRT)

Role
EVP, Operations
Signature
/s/ Melinda Lackey, Attorney-in-Fact
Stock symbol
TCRT
Transactions as of
Mar 30, 2022
Transactions value $
$0
Form type
4
Date filed
4/1/2022, 04:30 PM
Previous filing
Dec 27, 2021

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TCRT Employee Stock Option (right to buy) Award $0 +350K $0.00 350K Mar 30, 2022 Common Stock 350K $0.66 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 One-sixteenth of the shares underlying the option vest in equal quarterly installments commencing three months after January 1, 2022, subject to the Reporting Person's continued service through each such date.

Remarks:

Exhibit List - Exhibit 24 - Power of Attorney